Prostate Cancer Awareness Month

503 views

Published on

September is National Prostate Cancer Awareness Month, and Philadelphia CyberKnife encourages men seeking prostate cancer treatment to educate themselves on the range of options available to treat the disease.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
503
On SlideShare
0
From Embeds
0
Number of Embeds
208
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Prostate Cancer Awareness Month

  1. 1. Did you know? September is Prostate Cancer Awareness MonthA  Service  of  Delaware  County  Memorial  Hospital   2010  West  Chester  Pike  Suite  115  Havertown,  PA  19083      (610)  446-­‐6850        www.phillycyberknife.com
  2. 2. Did you know? The  American  Cancer  Society  esFmates  241,740  new  prostate   cancer  diagnoses  in  2012.   Quick  stats:     •  1  in  6  men  will  be  diagnosed  with  prostate   cancer  during  his  life:me.   •  Prostate  cancer  occurs  mainly  in  older   men.  Nearly  two-­‐thirds  of  cases  are   diagnosed  in  men  aged  65  or  above,  and  it   is  rare  before  age  40.  The  average  age  at   the  :me  of  diagnosis  is  about  67.     •  More  than  2.5  million  men  in  the  United   States  who  have  been  diagnosed  with   prostate  cancer  at  some  point  are  s:ll  alive   today,  thanks  to  advancements  in   treatment.  2010  West  Chester  Pike  Suite  115  Havertown,  PA  19083      (610)  446-­‐6850        www.phillycyberknife.com
  3. 3. Did you know? CyberKnife  can  noninvasively  treat  prostate  cancer  in  five  or  fewer   treatment  sessions.   How  it  works:   •  CyberKnife  treats  prostate  cancer  with  a  procedure  called   stereotac:c  body  radia:on  therapy,  a  noninvasive  method  of   trea:ng  tumors  with  precisely  targeted  high-­‐dose  radia:on.  The   result  is  greatly  increased  accuracy  that  spares  healthy  Fssue.       •  Prior  to  treatment,  small  metal  :ssue  markers  known  as  fiducials   are  implanted  in  the  prostate  to  help  the  CyberKnife  pinpoint  the   tumor  loca:on  throughout  each  treatment,  ensuring  the   radiaFon  beams  delivered  during  treatment  are  always  locked   on  the  tumor.     •  Pa:ents  are  then  scheduled  for  no  more  than  five  CyberKnife   treatments.  Each  treatment  takes  about  30  -­‐  40  minutes,  and   paFents  can  return  to  their  normal  rouFnes  following  each   procedure.   •  In  recent  years,  CyberKnife  has  gained  awareness  among  prostate   cancer  pa:ents  in  par:cular.  Many  men  are  drawn  to  the   convenience  of  shorter  treatment  and  fewer  side  effects.    2010  West  Chester  Pike  Suite  115  Havertown,  PA  19083      (610)  446-­‐6850        www.phillycyberknife.com
  4. 4. Our Center Philadelphia CyberKnife established the first CyberKnife program in the greater Philadelphia area and has one of the most experienced CyberKnife clinical teams in the region. The center is actively engaged in research with team members publishing several scientific papers on the treatment of prostate cancer. Philadelphia CyberKnife is a service of Delaware County Memorial Hospital, a member of the Crozer-Keystone Health System. Medical Director: Dr. Luther Brady Associate Medical Director: Dr. John Lamond DCMH Chief of Radiation Oncology: Dr. Rachelle Lanicano Chief Medical Physicist: Jun Yang, Ph.D., DABR CyberKnife Nurse: Michael GoodOther Resources 2010  West  Chester  Pike  Suite  115  Havertown,  PA  19083      (610)  446-­‐6850        www.phillycyberknife.com

×